Effects of Environmental Enrichment on Neurotrophins in an MPTP-Induced Parkinson’s Disease Animal Model: A Randomized Trial

Abstract

The aim of this study was to investigate the effect of environmental enrichment (EE) on neurotrophin expression in an animal model of Parkinson’s disease (PD). PD was induced via intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Male mice (N = 42) were randomly divided into 3 groups: control, MPTP + standard condition (SC), and MPTP + EE. The groups were raised separately for 28 days. On Day 21 they received 1 injection (20 mg/kg MPTP or saline for MPTP and control groups, respectively) every 2 hr for a total of 4 injections. Animals were sacrificed 7 days after the final injection and their brains were immediately removed. Neurotrophins and messenger ribonucleic acid (mRNA) expression levels were measured. The BCL-2/Bax ratio significantly increased in the MPTP + EE compared to the MPTP + SC group. Nerve growth factor (NGF) mRNA level was upregulated (but not significantly) in the MPTP + EE compared to the MPTP + SC group. Tyrosine hydroxylase (TH) expression significantly increased in the MPTP + EE compared to the MPTP + SC group. Finally, expressions of proNGF and p75 neurotrophin receptor (p75^NTR) were significantly downregulated in the MPTP + EE compared to the MPTP + SC group. Results confirm that EE has neuroprotective effects on dopaminergic neurons via suppression of activation of the p75^NTR-mediated signaling pathway through the binding of proNGF and p75^NTR. Findings suggest that use of EE as a therapeutic intervention would promote healthy aging by facilitating recovery following brain injury and preventing neurodegenerative diseases.

Keywords

environmental enrichment neuroprotection neurotrophins Parkinson’s disease

Get full access to this article

View all access options for this article.

References

Arnaiz

S. L.

D’Amico

Paglia

Arismendi

Basso

del Rosario

Arnaiz

(2004). Enriched environment, nitric oxide production and synaptic plasticity prevent the aging-dependent impairment of spatial cognition. Molecular Aspects of Medicine, 25(1-2), 91–101. https://doi.org/10.1016/j.mam.2004.02.011

Baek

H. C.

Lim

W. J.

(2019). Effect of nurse-led community comprehensive exercise program for elderly with chronic osteoarthritis. Journal of Korean Academic Society of Home Health Care Nursing, 26(1), 102–110. https://doi.org/10.22705/jkashcn.2019.-26.1.102

Barcelona

P. F.

Saragovi

H. U.

(2015). A pro-nerve growth factor (proNGF) and NGF binding protein, α2-macroglobulin, differentially regulates p75 and TrkA receptors and is relevant to neurodegeneration ex vivo and in vivo. Molecular and Cellular Biology, 35(19), 3396–3408. https://doi.org/10.1128/mcb.00544-15

Cabello

C. R.

Thune

J. J.

Pakkenberg

(2002). Ageing of substantia nigra in humans: Cell loss may be compensated by hypertrophy. Neuropathology and Applied Neurobiology, 28(4), 283–291. https://doi.org/10.1046/j.1365-2990.2002.00393.x

Connolly

B. S.

Lang

A. E.

(2014). Pharmacological treatment of Parkinson disease: A review. JAMA, 311, 1670–1683. https://doi.org/10.1001/jama.2014.3654

Elbaz

Carcaillon

Kab

Moisan

(2016). Epidemiology of Parkinson’s disease. Revue Neurologique, 172(1), 14–26. https://doi.org/10.1016/j.neurol.2015.09.012

Etminan

Gill

S. S.

Samii

(2005). Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: A meta-analysis. Lancet Neurology, 4, 362–365. https://doi.org/10.1016/s1474-4422(05)70097-1

Faherty

C. J.

Raviie Shepherd

Herasimtschuk

Smeyne

R. J.

(2005). Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Molecular Brain Research, 134(1), 170–179. https://doi.org/10.1016/j.molbrainres.2004.08.008

Fahnestock

Shekari

(2019). ProNGF and neurodegeneration in Alzheimer’s disease. Frontiers in Neuroscience, 13, 129–139. https://doi.org/10.3389/fnins.2019.00129

10.

Fahnestock

Michalski

Mathew

Colquhoun

Ross

G. M.

Coughlin

M. D.

(2004). The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. Journal of Neurochemistry, 89(3), 581–592. https://doi.org/10.1111/j.1471-4159.2004.02360.x

11.

Friedman

W. J.

(2000). Neurotrophins induce death of hippocampal neurons via the p75 receptor. Journal of Neuroscience, 20(17), 6340–6346. https://doi.org/10.1523/JNEUROSCI.20-17-06340.2000

12.

Gelfo

Cutuli

Foti

Laricchiuta

De Bartolo

Caltagirone

Petrosini

Angelucci

(2010). Enriched environment improves motor function and increases neurotrophins in hemicerebellar lesioned rats. Neurorehabilitation and Neural Repair, 25(3), 243–252. https://doi.org/10.1177/1545968310380926

13.

Hennigan

O’Callaghan

R. M.

Kelly

A. M.

(2007). Neurotrophins and their receptors: Roles in plasticity, neurodegeneration and neuroprotection. Biochemical Society Transactions, 35(2), 424–427. https://doi.org/10.1042/bst0350424

14.

Hubrecht

Kirkwood

(Eds.) (2010). The care and management of laboratory and other research animals (8th ed.). John Wiley & Sons.

15.

Jackson-Lewis

Przedborski

(2007). Protocol for the MPTP mouse model of Parkinson’s disease. Nature Protocols, 2(1), 141–151. https://doi.org/10.1038/nprot.2006.342

16.

Jungling

Reglodi

Karadi

Z. N.

Horvath

Farkas

Gaszner

Tamas

(2017). Effects of postnatal enriched environment in a model of Parkinson’s disease in adult rats. International Journal of Molecular Sciences, 18(2), 406. https://doi.org/10.3390/ijms18020406

17.

Kalia

L. V.

Lang

A. E.

(2015). Parkinson’s disease. Lancet, 386(9996), 896–912. https://doi.org/10.1016/s0140-6736(14)61393-3

18.

Kobilo

Liu

Q. R.

Gandhi

Mughal

Shaham

van Praag

(2011). Running is the neurogenic and neurotrophic stimulus in environmental enrichment. Learning & Memory, 18(9), 605–609. https://doi.org/10.1101/lm.2283011

19.

Lee

J. E.

Choi

J. K.

Lim

H. S.

Kim

J. H.

Cho

J. H.

Kim

G. S.

Lee

P. H.

Sohn

Y. H.

Lee

J. H.

(2017). The prevalence and incidence of Parkinson’s disease in South Korea: A 10-year nationwide population-based study. Journal of the Korean Neurological Association, 35(4), 191–198. https://doi.org/10.17340/jkna.2017.4.1

20.

Mora

Segovia

del Arco

(2007). Aging, plasticity and environmental enrichment: Structural changes and neurotransmitter dynamics in several areas of the brain. Brain Research Reviews, 55(1), 78–88, https://doi.org/10.1016/j.brainresrev.2007.03.011

21.

Nithianantharajah

Hannan

A. J.

(2006). Enriched environments, experience dependent plasticity and disorders of the nervous system. Nature Reviews Neuroscience, 7(9), 697–709. https://doi.org/10.1038/nrn1970

22.

Park

Y. H.

H. Y.

(2019). Development and evaluation of a community based multifaceted cognitive training program for the elderly with mild cognitive impairment. Journal of Korean Academy of Community Health Nursing, 30(2), 119–129. https://doi.org/10.12799/jkachn.2019.30.2.119

23.

Pedre

L. L.

Pavón

F. N.

Alvarez

G. L.

McRae

Sánchez

Blanco Lescano

González

(2002). Nerve growth factor levels in Parkinson disease and experimental Parkinsonian rats. Brain Research, 952(1), 122–127. https://doi.org/10.1016/S0006-8993(02)03222-5

24.

Pham

T. M.

Winblad

Granholm

A. C.

Mohammed

A. H.

(2002). Environmental influences on brain neurotrophins in rats. Pharmacology, Biochemistry and Behavior, 73(1), 167–175. https://doi.org/10.1016/s0091-3057(02)00783-9

25.

Rafii

M. S.

Baumann

T. L.

Bakay

R. A.

Ostrove

J. M.

Siffert

Fleisher

A. S.

Herzog

C. D.

Barba

Pay

Salmon

D. P.

Chu

Kordower

J. H.

Bishop

Keator

Potkin

Bartus

R. T.

(2014). A phase 1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease. Alzheimer’s & Dementia, 10(5), 571–581. https://doi.org/10.1016/j.jalz.2013.09.004

26.

Seong

H. H.

Park

J. M.

Kim

Y. J.

(2018). Antidepressive effects of environmental enrichment in chronic stress-induced depression in rats. Biological Research for Nursing, 20, 40–48. https://doi.org/10.1177/1099800417730400

27.

Sohng

K. Y.

Moon

J. S.

Lee

K. S.

Choi

D. W.

(2007). The development and effects of a self-management program for patients with Parkinson’s disease. Journal of Korean Academy of Nursing, 37(6), 891–901. https://doi.org/10.4040/jkan.2007.37.6.891

28.

Turner

C. A.

Lewis

M. H.

(2003). Environmental enrichment: Effects on stereotyped behavior and neurotrophin levels. Physiology & Behavior, 80(2-3), 259–266. https://doi.org/10.1016/j.physbeh.2003.07.008

29.

Van Praag

Kempermann

Gage

F. H.

(2000). Neural consequences of environmental enrichment. Nature Review Neuroscience, 1(3), 191–198. https://doi.org/10.1038/35044558

30.

Vila

Jackson-Lewis

Vukosavic

Djaldetti

Liberatore

Offen

(2001). Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson’s disease. PNAS, 98(5), 2837–2842. https://doi.org/10.1073/pnas.051633998

31.

Volosin

Song

Almeida

R. D.

Kaplan

D. R.

Hempstead

B. L.

Friedman

W. J.

(2006). Interaction of survival and death signaling in basal forebrain neurons: Roles of neurotrophins and proneurotrophins. Journal of Neuroscience, 26(29), 7756–7766. https://doi.org/10.1523/jneurosci.1560-06.2006

32.

Zhu

S. W.

Yee

B. K.

Nyffeler

Winblad

Feldon

Mohammed

A. H.

(2006). Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behavioural Brain Research, 169(1), 10–20. https://doi.org/10.1016/j.bbr.2005.11.024